Target intelligence / Profile preview

Nudix hydrolase 22 (NUDT22)

Target
NUDT22
Molecular classification
Enzyme, Nudix hydrolase
01

Overview

Nudix hydrolase 22 (NUDT22) is a member of the Nudix (nucleoside diphosphate linked moiety X) protein family and functions as a Mg²⁺-dependent UDP-glucose and UDP-galactose hydrolase, hydrolyzing these substrates into UMP and glucose 1-phosphate or galactose 1-phosphate, respectively[1][2]. It possesses a unique structural fold within the Nudix family, including a modified NUDIX box and a distinct N-terminal domain associated with substrate recognition[1]. Located in the nucleoplasm, NUDT22 is involved in nucleotide and carbohydrate metabolism and may play roles in cellular metabolic homeostasis[2][3]. Expression analyses indicate potential relevance in cancer, as levels can differ between normal and tumor tissues[3]. Currently, there are no known drugs that target NUDT22, nor is it established as a biomarker or has documented safety concerns for therapeutic intervention[2][3].

Other names
NUDT22UDP-glucose hydrolaseUDP-galactose hydrolaseUDP-sugar diphosphatase
02

Mechanism of action

Hydrolysis of UDP-glucose and UDP-galactose to produce UMP and glucose 1-phosphate or galactose 1-phosphate

03

Biological functions

Carbohydrate metabolismNucleotide metabolismCellular homeostasis
04

Disease associations

Cancer (potentially implicated due to altered expression in some tumors)Chromosome 17q12 deletion syndrome (associated disease)

Beyond the preview

Go deeper on Nudix hydrolase 22 (NUDT22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nudix hydrolase 22 (NUDT22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call